The global breast imaging market size is anticipated to reach USD 9.0 billion by 2030, registering a CAGR of 8.6% according to a new report by Grand View Research, Inc. The market growth mainly owes to the increase in the number of women suffering from breast cancer. For instance, according to Robert Koch Institute, the annual incidence of breast cancer in Germany was estimated to be approximately 72,000, with breast cancer being the most prevalent cancer in women. Moreover, as per a similar source, based on the incidence rate, one in eight women is expected to suffer from breast cancer once in a lifetime. Thus, impelling the market over the forecast period.
Furthermore, the rising initiatives by various governments and NGOs to raise awareness about early diagnosis of breast cancer are anticipated to increase the demand for breast imaging. For instance, Pink Initiative, form Breast Cancer India is an online initiative program in which the program covers important topics such as early detection of breast cancer, and familial breast cancer, through their YouTube channel. Similarly, a joint initiative between Australian & state territory governments, ‘BreastScreen Australia’ is aimed at reducing deaths & illness from breast cancer by early detecting cancer. In this program, women aged 40 and above can have a free mammogram every 2 years. This is expected to increase awareness, and increase the demand for breast imaging, thereby, propelling the market growth.
Major manufacturers are introducing new products and increasing the number of approved products, which is further expected to impel the demand in the coming years. For instance, in March 2018, The MAMMOMAT Revelation platform, from Siemens Healthineers, for enhanced mammography has been approved by the U.S. FDA. To target afflicted areas with only one click, this platform combines a new InSpect specimen imaging tool and new HD Breast Biopsy technology. In addition, the use of artificial intelligence (AI) in breast imaging has reduced the time required while maintaining image quality. Such product developments are expected to propel market growth.
Request a free sample copy or view report summary: Breast Imaging Market Report
The ionizing segment dominated the technology segment in 2022 owing to the introduction of new ionizing technology-based breast imaging technologies.
Hospitals dominated the end-use segment in 2022 due to the presence of advanced and well-equipped breast imaging facilities.
In 2022, North America dominated the breast imaging market with a market share of 37.87% 2022. This can be accredited to the rising number of breast cancer cases in this region.
Asia Pacific is projected to impel at the fastest growth rate of CAGR 9.5% during the forecast duration. Increased prevalence of breast cancer, high R&D investments in breast cancer therapies, and developments in breast imaging modalities are the primary drivers driving the growth of the market.
Grand View Research has segmented the global breast imaging market based on technology, end-use, and region:
Breast Imaging Technology Outlook (Revenue, USD Million; 2018 - 2030)
Full-field Digital Mammography
Positron Emission Mammography
Electric Impedance Tomography
Cone-Beam Computed Tomography
Positron Emission Tomography & Computed Tomography
3D Breast Tomosynthesis
Automated Whole-breast Ultrasound
Breast Imaging End-use Outlook (Revenue, USD Million; 2018 - 2030)
Breast Care Centers
Diagnostic Imaging Centers
Breast Imaging Regional Outlook (Revenue, USD Million; 2018 - 2030)
List Of Key Players in the Breast Imaging Market
Gamma Medica, Inc.
Fujifilm Holdings Corp.
Dilon Technologies, Inc.,
Aurora Imaging Technology, Inc.
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
"The quality of research they have done for us has been excellent..."